PHOTO
- It helps reduce the time required for inventory monitoring and tracking by 80 per cent.
- It saves 4,640 hours per year
- It also saves 2.3 million sheets of printed-paper per year.
Dubai: The Dubai Health Authority (DHA) in collaboration with Smart Dubai launched today at the 40th GITEX Technology Week, a state-of-the-art fully automated paperless Drugs and Medical Supplies Management System known as Tarmeez making it the first government entity in the region to implement this international standard.
During the launch ceremony, Al Qutami said that the introduction of the TARMEEZ system will have a positive impact on enhancing efficiency of drugs and medical material management which is a crucial aspect of the healthcare system.
He emphasised that DHA is keen to utilize the latest digital technology and cutting-edge solutions to enhance the health sector in Dubai and ensure the highest quality of accessible care for patients.
Al Qutami said this project is of significant importance and will aid in the Authority’s goal of providing the highest quality of healthcare services and healthcare management using smart technology.
Al Qutami emphasised on the the authority's keenness to fully implement the Dubai Paperless Strategy and its key objectives.
The Strategy was launched in February 2018 by His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai and Chairman of the Executive Council of Dubai. It seeks to eliminate the use of paper from all internal operations and customer facing services across Dubai government entities by the end of 2021.
Ghanim Lootah, Director of Asset Management at the DHA said, “The introduction of this system has multiple benefits and is in line with the DHA Strategy 2016-2021 as well as the Dubai Paperless Strategy. The drug and medical supplies material management system helps tracks orders, monitors supply and usage of stored medication and medical materials digitally. It helps us better handle and manage drugs and medical materials, track documentation and information, and reduce both operational costs and medication waste. To better determine which drugs should be regularly re-ordered, we can look at the system, which provides an in-depth overview of utilization management. Since it all digital the saving in terms of time, cost and resources is significant.
Lootah added that the system provides 100% accuracy in drugs and medical supplies identification for patients’ safety. It helps reduces the time required for inventory monitoring and tracking by 80 per cent. It saves 4,640 hours per year and it saves 2.3 million sheets of printed-paper per year.
He added that the DHA is currently coordinating with more than 183 international manufacturers and 42 local factories and distributers.
The system provides DHA medical staff across hospitals, primary and specialised health centres with an electronic catalog of all the items available. It offers a central dashboard for inventory and supply chain KPI details.
He added that TARMEEZ is integrated with Salama- the Dubai Health Authority's (DHA) unified electronic medical record system.
-Ends-
For further information, please contact:
Kamakshi Gupta and Noor Nazzal
Communications Analysts- Media Dept.
Dubai Health Authority
klgupta@dha.gov.ae nnnazzal@dha.gov.ae
+9714 2197455
About the Dubai Health Authority:
The Dubai Health Authority (DHA) was created, in June 2007, by Law 13 issued by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE, Ruler of Dubai, with an expanded vision to include strategic oversight for the complete health sector in Dubai and enhance private sector engagement.
Prior to the establishment of the DHA, the Department of Health and Medical Services, which was established in 1973, was the functioning authority that almost exclusively focused on health service delivery.
In May 2018, H.H Sheikh Mohammed, issued Law No. (6) of 2018 of the DHA. The new Law further enables the DHA to achieve its objectives including regulating medical services in Dubai, enhancing competiveness and transparency, improving medical services and products based on international best practices and achieving the sector’s objectives according to approved strategic plans.
H.H Sheikh Mohammed also issued Decree No. 17 of 2018 establishing subsidiaries of the DHA: the Dubai Healthcare Corporation and Dubai Health Insurance Corporation to further enhance healthcare services in Dubai and enable DHA to fulfil its responsibilities and obligations.
Three new strategic sectors were also added as part of the decree; they include Strategy and Corporate Development, Health Regulation, and Shared Support Services.
In addition to overseeing the health sector for the Emirate of Dubai, the DHA also focuses on providing services through DHA healthcare facilities including Latifa, Dubai, Rashid and Hatta Hospitals, its 12 primary healthcare centres, 17 medical fitness centres and its 6 specialty centres.
For more information, visit DHA’s website: www.dha.gov.ae
© Press Release 2020
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
